BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lasa J, Correa G, Fuxman C, Garbi L, Linares ME, Lubrano P, Rausch A, Toro M, Yantorno M, Zubiaurre I, Peyrin-Biroulet L, Olivera P. Treatment Adherence in Inflammatory Bowel Disease Patients from Argentina: A Multicenter Study. Gastroenterol Res Pract 2020;2020:4060648. [PMID: 32411197 DOI: 10.1155/2020/4060648] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 D'Amico F, Peyrin-Biroulet L, Danese S, Fiorino G. New drugs in the pipeline for the treatment of inflammatory bowel diseases: what is coming? Curr Opin Pharmacol 2020;55:141-50. [PMID: 33254032 DOI: 10.1016/j.coph.2020.10.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Santos JDM, Peña-Sánchez JN, Fowler SA. Patients' perspectives on medication for inflammatory bowel disease: a mixed-method systematic review. Eur J Gastroenterol Hepatol 2021;33:1139-47. [PMID: 32773507 DOI: 10.1097/MEG.0000000000001861] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Nascimento RPD, Machado APDF, Lima VS, Moya AMTM, Reguengo LM, Bogusz Junior S, Leal RF, Cao-Ngoc P, Rossi JC, Leclercq L, Cottet H, Cazarin CBB, Marostica Junior MR. Chemoprevention with a tea from hawthorn (Crataegus oxyacantha) leaves and flowers attenuates colitis in rats by reducing inflammation and oxidative stress. Food Chem X 2021;12:100139. [PMID: 34712949 DOI: 10.1016/j.fochx.2021.100139] [Reference Citation Analysis]
4 Brenner EJ, Long MD, Kappelman MD, Zhang X, Sandler RS, Barnes EL. Development of an Inflammatory Bowel Disease-Specific Medication Adherence Instrument and Reasons for Non-adherence. Dig Dis Sci 2022. [PMID: 35503483 DOI: 10.1007/s10620-022-07517-5] [Reference Citation Analysis]